Talk:Merck Group

Archives (Index)

2012 2016 2017 2018

This page is archived by ClueBot III.

Precision Farming

"Merck got into cow collars in 2019 when it bought Allflex, a company that makes them, betting that the animal health industry would grow. Merck sells the collars and software for a monthly subscription of around $3 a cow and monitors over two million cows, or 20 percent of the U.S. herd. The company also sells ear tags that light up blue to show farmers which cows to tend to."(NewYorktimes, 2025)

https://www.nytimes.com/2025/10/05/technology/cows-ai-collars.html?smid=nytcore-ios-share&referringSource=articleShare SeriousLeeFiction (talk) 14:46, 5 October 2025 (UTC)

Suggestion to update management and financials

Dear all,

I would like to suggest to update the key people section as well as the financials in the infobox. Please note that I have a financial conflict of interest as I am an employee of Merck Group.

Suggested changes to the Infobox

CEO

1. Please remove the current CEO in the key people section:

Belén Garijo (CEO and chairman of the executive board)

2. Please add the Kai Beckmann as CEO to the key people section:

Kai Beckmann (CEO and chairman of the executive board)

3. Using as the reference:

Smolak, Helena (2025-09-25). "Kai Beckmann wird Nachfolger von Belén Garijo bei Merck". Handelsblatt (in German). Retrieved 2026-05-06.

4. Reason for change being made:

Change of CEO effective 1 May 2026.

Revenue

1. Please remove the current revenue in the infobox:

€21.16 billion (2024)

2. Please add the following as revenue to the infobox:

€21.10 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 2. Retrieved 2026-05-06.

4. Reason for change being made:

Revenue for fiscal year 2025.

Operating Income

1. Please remove the current operating income in the infobox:

€3.645 billion (2024)

2. Please add the following as operating income to the infobox:

€3.601 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 2. Retrieved 2026-05-06.

4. Reason for change being made:

Operating income for fiscal year 2025.

Net Income

1. Please remove the current net income in the infobox:

€2.777 billion (2024)

2. Please add the following as net income to the infobox:

€2.615 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 2. Retrieved 2026-05-06.

4. Reason for change being made:

Net income for fiscal year 2025.

Assets

1. Please remove the current assets in the infobox:

€51.57 billion (2024)

2. Please add the following as assets to the infobox:

€51.53 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 64. Retrieved 2026-05-06.

4. Reason for change being made:

Assets for fiscal year 2025.

Equity

1. Please remove the current equity in the infobox:

€29.99 billion (2024)

2. Please add the following as equity to the infobox:

€28.66 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 64. Retrieved 2026-05-06.

4. Reason for change being made:

Equity for fiscal year 2025.

Employees

1. Please remove the current number of employees in the infobox:

62,557 (2024)

2. Please add the following as number of employees to the infobox:

62,461 (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 3. Retrieved 2026-05-06.

4. Reason for change being made:

Number of employees as of 31 december 2025.

I am looking forward to feedback from independent editors. Greatly appreciate everybody’s time for this! Best, Heinrich-Emanuel (talk) 08:20, 6 May 2026 (UTC)

 Done. Infobox updates are not critical. Grimes2 17:39, 6 May 2026 (UTC)

@Grimes2: I've closed the request. Feel free to reopen it if you want, but please remember to close requests (see the template's docs) when you're done, it is especially important when the queue is so long. Seercat3160 (talk) 07:49, 10 May 2026 (UTC)

Suggestion for update

Dear all, I would like to suggest to update one information in the article related to the brand use of Merck inside and outside the U.S. and Canada as well as an update of the picture in the info box of our headquarters as the current picture is outdated (pyramide does not exist anymore) Please note that I have a financial conflict of interest as I am an employee of Merck Group.

Introduction

1. Please remove the last two sentences of the fourth paragraph of the article: The original Merck of Darmstadt holds the rights to the name Merck in all countries except the U.S. and Canada, where it is known as EMD (Emanuel Merck, Darmstadt), and the life science business specifically is known as MilliporeSigma. In 2015 Merck adopted a uniform brand identity for all its subsidiaries, and the company has stressed its intention to protect the brand of "the real Merck" globally and initiated litigation against its former subsidiary over use of the name.

2. Please add the following as the last two sentences of the fourth paragraph to the article: Merck KGaA of Darmstadt holds the rights to the name Merck in all countries except the U.S. and Canada, where its businesses operate under "EMD Serono" in Healthcare, "MilliporeSigma" in Life Science and "EMD Electronics" in Electronics. Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada.

3. Using as the reference: {{cite web|title=Fight over Merck name sees German firm win in British court|url=https://www.reuters.com/article/us-merckkgaa-name-idUSKCN0UT239/|first=Ludwig|last=Burger|website=Reuters|date=2016-01-15|accessdate=2026-05-22%7D%7D

4. Reason for change being made: Suggestion to update the two sentences after court rule in 2016.

 Not done @Heinrich-Emanuel: For two reasons. First, the lead is supposed to summarize the article. Anything added or changed in the lead therefore needs to also be updated in the article. Second, the source you provided doesn't fully support the text. There's no mention of MillisporeSigma or the other companies. I'd find a place in the article to update the info, with a better source, and then we can change the lead. If the info is properly sourced in the body, there's no need to duplicate the source in the lead, and indeed it's discouraged per the manual of style. I marked the request under consideration with the "u" parameter. If you update the request, you can remove the "u" from the template so others will come to help. You can also ping me when you're done. STEMinfo (talk) 23:21, 5 August 2026 (UTC)

Info box

1. Please remove the current picture from the info box: Merck KGaA 01.jpg

2. Please add the following picture to the info box: Merck Headquarters.jpg

3. Reason for change being made: Pyramide distruction already in 2014. New picture shows current headquarter appearance.

 Done Logo replaced. STEMinfo (talk) 23:21, 5 August 2026 (UTC)

I am looking forward to feedback from independent editors. Please also let me know if you have any questions. Greatly appreciate everybody’s time for this! Best, Heinrich-Emanuel (talk) 07:30, 24 July 2026 (UTC)

@STEMinfo: Thank you very much for looking into this. In the following I updated the request. Actually, the sources for MilliporeSigma, EMD Sorono and EMD Electronics are already in the article today (sources 50, 64, 80). The corresponding wording in the article, however, isn't that clear. Therefore I added a few more suggestion to my request so that the text already in the article reflects the sources and ultimately allows a summary at the top.

History Section - 2010 onwards

1. Please remove the following sentence in the history section of the article:

In December of the same year, EMD Serono (Merck Group operations in the US and Canada) announced it would acquire Swiss-based Chord Therapeutics and its lead drug cladribine, used in generalised myasthenia gravis and neuromyelitis optica spectrum disorder.

2. Please add the following as the sentence instead: In December of the same year, EMD Serono (healthcare operations of the Merck Group in the US and Canada) announced it would acquire Swiss-based Chord Therapeutics and its lead drug cladribine, used in generalised myasthenia gravis and neuromyelitis optica spectrum disorder.

3. Using as the reference: current reference number 50: "EMD Serono Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics". www.biospace.com. 20 December 2021.

4. Reason for change being made:

Clarification that EMD Serono is not the entire Merck Group business in the US and Canada but its healthcare operation in the region.

Partly done The item was sourced to a press release. I couldn't find any independent coverage that mentioned EMD Serono, so I changed it to Merck KGaA to match the source. STEMinfo (talk) 01:11, 20 August 2026 (UTC)

History Section - name

1. Please remove the following sentence in the history section of the article:

On 7 December 2021, Merck, which uses the name EMD Electronics in North America, announced they would be investing $1 billion in a U.S. operations joint venture with Palantir Technologies to assist in solving some of the chip industries supply chain problems.

2. Please add the following as the sentence instead:

On 7 December 2021, Merck, which uses the name EMD Electronics for its North American electronics business, announced they would be investing $1 billion in a U.S. operations joint venture with Palantir Technologies to assist in solving some of the chip industries supply chain problems.

3. Using as the reference: current reference number 64: Nellis, Stephen (7 December 2021). "German chip chemical supplier to spend $1 bln in U.S., pairs with Palantir on supply chain data". Reuters. Retrieved 7 December 2021.

4. Reason for change being made:

Clarification that EMD Electronics is not the entire Merck Group business in North America but its electronics operation in the region.

 Done STEMinfo (talk) 01:11, 20 August 2026 (UTC)

Healthcare

1. Please add the following sentence as last sentence of the Healthcare section of the article:

In the U.S. and Canada, the healthcare business of Merck operates as “EMD Serono”.

2. Using as the reference: current reference number 50: "EMD Serono Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics". www.biospace.com. 20 December 2021.

3. Reason for change being made:

Suggestion to add the sentence in the healthcare section of the article to clarify clearly that EMD Serono is the name of th healthcare business in the US and Canada.

 Not done Can you find an independent source that substantiates EMD Serono? STEMinfo (talk) 01:11, 20 August 2026 (UTC)

Electronics

1. Please add the following sentence as last sentence of the Healthcare section of the article:

In the U.S. and Canada, the electronics business of Merck operates as “EMD Electronics”.

2. Using as the reference: current reference number 64: Nellis, Stephen (7 December 2021). "German chip chemical supplier to spend $1 bln in U.S., pairs with Palantir on supply chain data". Reuters. Retrieved 7 December 2021.

3. Reason for change being made:

Suggestion to add the sentence in the electronics section of the article to clarify clearly that EMD Electronics is the name of the electronics business in the US and Canada.

 Done STEMinfo (talk) 01:24, 20 August 2026 (UTC)

Introduction

1. Please remove the last two sentences of the fourth paragraph of the article:

The original Merck of Darmstadt holds the rights to the name Merck in all countries except the U.S. and Canada, where it is known as EMD (Emanuel Merck, Darmstadt), and the life science business specifically is known as MilliporeSigma. In 2015 Merck adopted a uniform brand identity for all its subsidiaries, and the company has stressed its intention to protect the brand of "the real Merck" globally and initiated litigation against its former subsidiary over use of the name.

2. Please add the following as the last two sentences of the fourth paragraph to the article:

Merck KGaA of Darmstadt holds the rights to the name Merck in all countries except the U.S. and Canada, where its businesses operate under "EMD Serono" in Healthcare, "MilliporeSigma" in Life Science and "EMD Electronics" in Electronics. Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada.

3. Using as the reference:

As per current sources in the text numbers 50, 58, 64, and 80.

4. Reason for change being made:

Suggestion to update the two sentences after court rule in 2016.

 Done and I salvaged the source about the confused protesters. STEMinfo (talk) 01:24, 20 August 2026 (UTC)

I hope uninvolved editors will review these suggestions. Let me know if there are any questions. Best, Heinrich-Emanuel (talk) 13:51, 17 August 2026 (UTC)

@STEMinfo: Thanks so much for your help with this. Here are also a few independent secondary sources regarding EMD Serono. Do you think any of these would work to implement the change suggested for the healthcare section above?

• Eaton, Elizabeth S. (2025-10-17). "TrumpRx welcomes Merck KGaA, one of nine to receive new priority voucher". FirstWord Pharma. Retrieved 2026-08-26.
• "EMD Serono partners US government to widen IVF access". Pharmaceutical Technology. 2025-10-17. Retrieved 2026-08-26.
• Wingrove, Patrick (2025-10-17). "Trump, Merck KGaA announce deal to cut some IVF drug prices". Reuters. Retrieved 2026-08-26.

What do you think? Looking forward to your continuous feedback. Best, Heinrich-Emanuel (talk) 07:44, 26 August 2026 (UTC)

Done STEMinfo (talk) 23:58, 10 September 2026 (UTC)